Echo Therapeutics, Inc. announced that Alan W. Schoenbart, currently the company's Chief Financial Officer, was appointed by the board of directors of the company to serve as Interim Chief Executive Officer of the company. Mr. Schoenbart will also continue as Chief Financial Officer. A biography for Mr. Schoenbart is contained in the company's definitive proxy statement filed on April 12, 2016 under the section entitled Executive Compensation.